Bank of America
ARTL icon

Bank of America’s Artelo Biosciences ARTL Stock Holding History

Bank of America’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$21 – 5765
2025
Q4 		$21 Buy
+1
New +$70 ﹤0.01% 7110
2025
Q3 		– Hold
0
– – – 8006
2025
Q2 		– Hold
0
– – – 8044
2025
Q1 		– Hold
0
– – – 8097
2024
Q4 		– Hold
0
– – – 7966
2024
Q3 		– Hold
0
– – – 7910
2024
Q2 		– Hold
0
– – – 7909
2022
Q1 		– Hold
0
– – – 8238
2021
Q4 		– Hold
0
– – – 8195
2021
Q3 		– Hold
0
– – – 7961
2021
Q2 		– Hold
0
– – – 7731
2021
Q1 		– Hold
0
– – – 7405

Other funds holding ARTL

AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Bank of America's ARTL Position: Q1 2026 in Review

Bank of America sold out of Artelo Biosciences (ARTL) in Q1 2026, closing a stake of 1 share — an estimated $21 sold.

Bank of America first reported a position in ARTL in Q4 2025 and held it in 1 quarter. The position peaked at $21 in Q4 2025. 8 funds tracked by Wall St. Rank hold ARTL as of Q1 2026.

  • Bank of America reported no remaining Artelo Biosciences position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 1 Artelo Biosciences share in Q1 2026, an estimated $21.
  • Bank of America first reported a position in Artelo Biosciences in Q4 2025 and held it in 1 quarter.
  • Bank of America's Artelo Biosciences position peaked at $21 in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.